Wednesday - March 18, 2026

Category Archives: Business

IKAN Health Recognizes CoreAge Rx as the Best GLP-1 Brand for Patients Without Insurance, Citing No Waitlist Policy and Free 2-Day Shipping as Standout Features

Independent health publication highlights CoreAge Rx’s physician-supervised telehealth model, rapid medication access, and transparent treatment pathway for medically supervised weight management. IKAN Health, an independent health and wellness publication focused on evaluating emerging telehealth solutions, has recognized CoreAge Rx as … Continue reading →

Myotonic Dystrophy Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Dyne Therapeutics, Avidity Biosciences, Harmony Biosciences, AMO Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myotonic Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Myopia Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Ziemer Group, NIDEK CO., LTD, 2EyesVision, Carl Zeiss AG, Alcon, CooperVision, Topcon Healthcare

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myopia pipeline constitutes 8+ key companies continuously working towards developing 10+ Myopia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

Acute Kidney Injury Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Astellas Pharma, Amniotics, Guard Therapeutics, RegeneRx Biopharma, Cerenis

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute Kidney Injury pipeline constitutes 30+ key companies continuously working towards developing 30+ Acute Kidney Injury treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Projecting the Global Diabetes Care Devices Market Size to Expand at a 7.26% CAGR Through 2034, DelveInsight Analysis

Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast – 2034” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The diabetes care devices market is largely … Continue reading →

Duchenne Muscular Dystrophy Clinical Pipeline Accelerates: Over 75 Companies Advancing Next-Generation Therapies | DelveInsight

Duchenne Muscular Dystrophy Companies Duchenne Muscular Dystrophy Companies include Santhera Pharmaceuticals, Sarepta Therapeutics, Italfarmaco, Wave Life Sciences Ltd, FibroGen, EDG 5506 Edgewise Therapeutics, Fordadistrogene movaparvovec, Daiichi Sankyo, Sarepta Therapeutics, Inc., ENCell, Taiho Pharmaceutical, Solid Biosciences, Capricor, Nippon Shinyaku, Hansa Biopharma, … Continue reading →

IZERVAY Market to Witness Robust Growth Through 2034 Driven by Rising Geographic Atrophy Treatment Adoption, Strong Clinical Outcomes, and Expanding Global Footprint | DelveInsight

IZERVAY Market IZERVAY sales market forecast report provides a detailed market assessment of IZERVAY for approved indication like Dry age-related macular degeneration; as well as potential inidcations like Polypoidal choroidal vasculopathy; and Wet age-related macular degeneration in the 7MM. DelveInsight’s … Continue reading →

Ablation Devices Market to Reach USD 15.34 Billion by 2034, Growing at a CAGR of 8.38% Driven by Rising Chronic Disease Burden and Advancements in Minimally Invasive Technologies | DelveInsight

Ablation Devices Market Ablation Devices companies include Medtronic, Boston Scientific Corporation, Abbott, Johnson & Johnson Services Inc, AtriCure, Inc., Stryker, Smith & Nephew, Hologic, Inc., CONMED Corporation., Biotronik SE & Co. KG, AngioDynamics, Inc., BD, Terumo Corporation, Merit Medical Systems, … Continue reading →

Psoriasis Treatment Market to Surpass USD 57 Billion by 2034, Growing at a CAGR of 5.41% | DelveInsight

Psoriasis Treatment Market Psoriasis treatment companies include Galderma, Johnson & Johnson Services, Inc., Amgen Inc., AstraZeneca, Bausch Health Companies Inc., Pfizer Inc., GSK plc., Astellas Pharma Inc., Teva Pharmaceutical Industries Ltd., Eisai Co., Ltd., Medexus Pharmaceuticals, Inc., AbbVie Inc., Novartis … Continue reading →